Press "Enter" to skip to content

Access to dedicated vaccine website can increase uptake.

Many countries, including Australia, are moving towards building medical records and info available online. We believe a devoted website would complement eHealth, and help parents to make an informed decision. In Australia the measles, rubella and mumps measles are all serious viral diseases, which still occur. Current guidelines advise that children should be immunised with the MMR vaccine at 12 a few months of age. Kids receive their second dose of a combined measles, mumps, rubella and varicella vaccine at 18 months of age. Related StoriesNew initiative released to accelerate seek out effective HIV vaccineGHIT Fund invests $10.7 million to battle malaria, TB, leishmaniasis and dengueResearchers reveal why malaria vaccine provides only moderate safety among vaccinated childrenThe study, which builds on previous studies that show web-based info has a positive influence on vaccine uptake, surveyed 179 parents.‘This software speeds up our capability to do that.’.

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics organization, announced today its participation in a $2. The new grant will fund study over 2 yrs in the laboratories of Daniel Rader, M.D. Of the University of Pennsylvania School of Medication, Sekar Kathiresan, M.D. Of Massachusetts General Hospital and Harvard Medical School, and Alnylam. The purpose of this initiative is definitely to mechanistically measure the metabolic and molecular effects of 38 novel genes implicated by human genetic studies in prevention of cardiovascular disease also to discover and develop RNAi therapeutics towards these gene applicants.